Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata causes significant stigma and emotional distress, with many affected individuals not receiving adequate support or treatment.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

B-mode ultrasonography and shear-wave elastography can help predict androgenetic alopecia early.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

Alopecia areata treatments often don't lead to lasting improvement.

Aminexil clinical 5 effectively reduces hair loss and is well-tolerated.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

Stem cell treatment improved life quality and sexual function in women with hair loss.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Including special area involvement helps identify more psoriasis patients who may need systemic treatment.

A new model uses specific blood markers to predict if children's hair loss will return.

Many patients with Alopecia Areata have underlying autoimmune disorders, especially thyroid issues.

People with alopecia areata are more likely to have anxiety and depression and a lower quality of life.

The C-CAT tool helps assess and improve treatment for central centrifugal cicatricial alopecia.

Patients with alopecia areata have lower RBC folate levels, especially in severe cases.

The condition called 'acute diffuse and total alopecia of the female scalp' is actually a known condition named alopecia areata incognita.

Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.

Allergies, especially both seasonal and food, increase the risk of developing alopecia areata.

Dermoscopy is a useful tool for diagnosing and managing alopecia areata.

Alopecia Areata Incognita causes widespread hair thinning, and treatment with systemic corticosteroids and psychiatric support can lead to remission.

Botulinum toxin type A injections are not effective for severe alopecia areata.

A new method accurately measures DHEAS in blood, improving on current tests.

Trichoscopy is a useful and affordable tool for diagnosing Alopecia areata.

The conclusion is that a new method could improve the identification of autoimmune targets in alopecia areata, despite some limitations.

AI can improve alopecia areata diagnosis with high accuracy.

Higher levels of retinol-binding protein 4 are found in people with alopecia areata, but these levels don't relate to how severe the condition is.

Higher blood sugar levels may lead to more severe hair loss in women.

The Turkish version of the MAIA-2 Scale is valid and reliable for patients at a dermatology clinic.

A new pain-measuring system using sensors and AI can effectively detect pain in mice, which may help assess pain in humans and develop treatments.